nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—Feeling cold—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0446	CcSEcCtD
Carvedilol—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0365	CcSEcCtD
Carvedilol—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0115	0.026	CcSEcCtD
Carvedilol—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.0115	0.026	CcSEcCtD
Carvedilol—SELE—nephron tubule—nephrolithiasis	0.0108	0.0401	CbGeAlD
Carvedilol—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0227	CcSEcCtD
Carvedilol—VCAM1—nephron tubule—nephrolithiasis	0.00991	0.0369	CbGeAlD
Carvedilol—SELE—renal system—nephrolithiasis	0.0098	0.0364	CbGeAlD
Carvedilol—HIF1A—nephron tubule—nephrolithiasis	0.00954	0.0355	CbGeAlD
Carvedilol—GJA1—nephron tubule—nephrolithiasis	0.00925	0.0344	CbGeAlD
Carvedilol—SELE—cortex of kidney—nephrolithiasis	0.00922	0.0343	CbGeAlD
Carvedilol—VCAM1—renal system—nephrolithiasis	0.00901	0.0335	CbGeAlD
Carvedilol—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.00891	0.0201	CcSEcCtD
Carvedilol—VCAM1—kidney—nephrolithiasis	0.00871	0.0324	CbGeAlD
Carvedilol—HIF1A—renal system—nephrolithiasis	0.00867	0.0322	CbGeAlD
Carvedilol—VCAM1—cortex of kidney—nephrolithiasis	0.00849	0.0316	CbGeAlD
Carvedilol—CYP1A2—urine—nephrolithiasis	0.00842	0.0313	CbGeAlD
Carvedilol—GJA1—renal system—nephrolithiasis	0.00841	0.0313	CbGeAlD
Carvedilol—HIF1A—kidney—nephrolithiasis	0.00838	0.0312	CbGeAlD
Carvedilol—HIF1A—cortex of kidney—nephrolithiasis	0.00816	0.0304	CbGeAlD
Carvedilol—GJA1—kidney—nephrolithiasis	0.00813	0.0302	CbGeAlD
Carvedilol—CYP2C9—urine—nephrolithiasis	0.00799	0.0297	CbGeAlD
Carvedilol—GJA1—cortex of kidney—nephrolithiasis	0.00792	0.0294	CbGeAlD
Carvedilol—CYP2E1—urine—nephrolithiasis	0.00758	0.0282	CbGeAlD
Carvedilol—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00739	0.0167	CcSEcCtD
Carvedilol—NDUFC2—renal system—nephrolithiasis	0.00732	0.0272	CbGeAlD
Carvedilol—VEGFA—nephron tubule—nephrolithiasis	0.00731	0.0272	CbGeAlD
Carvedilol—NDUFC2—kidney—nephrolithiasis	0.00708	0.0263	CbGeAlD
Carvedilol—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00699	0.0157	CcSEcCtD
Carvedilol—NDUFC2—cortex of kidney—nephrolithiasis	0.00689	0.0256	CbGeAlD
Carvedilol—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00688	0.0155	CcSEcCtD
Carvedilol—VEGFA—cortex of kidney—nephrolithiasis	0.00625	0.0233	CbGeAlD
Carvedilol—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0137	CcSEcCtD
Carvedilol—CYP3A4—urine—nephrolithiasis	0.0061	0.0227	CbGeAlD
Carvedilol—Gout—Hydrochlorothiazide—nephrolithiasis	0.00606	0.0137	CcSEcCtD
Carvedilol—CYP2D6—urine—nephrolithiasis	0.006	0.0223	CbGeAlD
Carvedilol—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00598	0.0135	CcSEcCtD
Carvedilol—XDH—renal system—nephrolithiasis	0.00591	0.022	CbGeAlD
Carvedilol—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00576	0.013	CcSEcCtD
Carvedilol—XDH—kidney—nephrolithiasis	0.00571	0.0213	CbGeAlD
Carvedilol—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00566	0.0128	CcSEcCtD
Carvedilol—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00556	0.0125	CcSEcCtD
Carvedilol—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0055	0.0124	CcSEcCtD
Carvedilol—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00534	0.012	CcSEcCtD
Carvedilol—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00531	0.012	CcSEcCtD
Carvedilol—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00504	0.0114	CcSEcCtD
Carvedilol—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00475	0.0107	CcSEcCtD
Carvedilol—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00472	0.0106	CcSEcCtD
Carvedilol—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00466	0.0105	CcSEcCtD
Carvedilol—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00459	0.0103	CcSEcCtD
Carvedilol—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00451	0.0102	CcSEcCtD
Carvedilol—Injury—Hydrochlorothiazide—nephrolithiasis	0.00447	0.0101	CcSEcCtD
Carvedilol—ADRA1B—renal system—nephrolithiasis	0.00444	0.0165	CbGeAlD
Carvedilol—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00998	CcSEcCtD
Carvedilol—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00981	CcSEcCtD
Carvedilol—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00434	0.00977	CcSEcCtD
Carvedilol—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00973	CcSEcCtD
Carvedilol—ADRA1B—kidney—nephrolithiasis	0.00429	0.0159	CbGeAlD
Carvedilol—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00426	0.0096	CcSEcCtD
Carvedilol—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00952	CcSEcCtD
Carvedilol—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00929	CcSEcCtD
Carvedilol—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00926	CcSEcCtD
Carvedilol—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00926	CcSEcCtD
Carvedilol—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00408	0.00918	CcSEcCtD
Carvedilol—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00911	CcSEcCtD
Carvedilol—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00911	CcSEcCtD
Carvedilol—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00877	CcSEcCtD
Carvedilol—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00867	CcSEcCtD
Carvedilol—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00845	CcSEcCtD
Carvedilol—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00842	CcSEcCtD
Carvedilol—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00834	CcSEcCtD
Carvedilol—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00834	CcSEcCtD
Carvedilol—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00834	CcSEcCtD
Carvedilol—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00816	CcSEcCtD
Carvedilol—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00355	0.008	CcSEcCtD
Carvedilol—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00779	CcSEcCtD
Carvedilol—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00744	CcSEcCtD
Carvedilol—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00739	CcSEcCtD
Carvedilol—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00737	CcSEcCtD
Carvedilol—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00324	0.0073	CcSEcCtD
Carvedilol—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00323	0.00728	CcSEcCtD
Carvedilol—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00722	CcSEcCtD
Carvedilol—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00318	0.00717	CcSEcCtD
Carvedilol—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00707	CcSEcCtD
Carvedilol—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00703	CcSEcCtD
Carvedilol—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00701	CcSEcCtD
Carvedilol—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00699	CcSEcCtD
Carvedilol—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00693	CcSEcCtD
Carvedilol—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00302	0.0068	CcSEcCtD
Carvedilol—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00669	CcSEcCtD
Carvedilol—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00652	CcSEcCtD
Carvedilol—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00642	CcSEcCtD
Carvedilol—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00637	CcSEcCtD
Carvedilol—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00636	CcSEcCtD
Carvedilol—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0028	0.00631	CcSEcCtD
Carvedilol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00617	CcSEcCtD
Carvedilol—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00605	CcSEcCtD
Carvedilol—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00265	0.00597	CcSEcCtD
Carvedilol—ADRA2C—nephron tubule—nephrolithiasis	0.00261	0.00971	CbGeAlD
Carvedilol—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00566	CcSEcCtD
Carvedilol—ADRA1A—renal system—nephrolithiasis	0.00249	0.00927	CbGeAlD
Carvedilol—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00549	CcSEcCtD
Carvedilol—Tension—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00547	CcSEcCtD
Carvedilol—KCNH2—renal system—nephrolithiasis	0.00241	0.00895	CbGeAlD
Carvedilol—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00541	CcSEcCtD
Carvedilol—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00539	CcSEcCtD
Carvedilol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00536	CcSEcCtD
Carvedilol—ADRA2C—renal system—nephrolithiasis	0.00237	0.00883	CbGeAlD
Carvedilol—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00525	CcSEcCtD
Carvedilol—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00517	CcSEcCtD
Carvedilol—ADRA2C—kidney—nephrolithiasis	0.0023	0.00854	CbGeAlD
Carvedilol—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00515	CcSEcCtD
Carvedilol—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00226	0.00509	CcSEcCtD
Carvedilol—ADRA2C—cortex of kidney—nephrolithiasis	0.00224	0.00831	CbGeAlD
Carvedilol—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00503	CcSEcCtD
Carvedilol—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00222	0.00501	CcSEcCtD
Carvedilol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00222	0.005	CcSEcCtD
Carvedilol—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00221	0.00499	CcSEcCtD
Carvedilol—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00219	0.00493	CcSEcCtD
Carvedilol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00217	0.0049	CcSEcCtD
Carvedilol—Cough—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00486	CcSEcCtD
Carvedilol—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00475	CcSEcCtD
Carvedilol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00475	CcSEcCtD
Carvedilol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00475	CcSEcCtD
Carvedilol—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00469	CcSEcCtD
Carvedilol—CYP1A2—renal system—nephrolithiasis	0.00206	0.00766	CbGeAlD
Carvedilol—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00464	CcSEcCtD
Carvedilol—CYP2E1—nephron tubule—nephrolithiasis	0.00204	0.00758	CbGeAlD
Carvedilol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00459	CcSEcCtD
Carvedilol—CYP1A1—renal system—nephrolithiasis	0.00203	0.00756	CbGeAlD
Carvedilol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00455	CcSEcCtD
Carvedilol—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00455	CcSEcCtD
Carvedilol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00199	0.00448	CcSEcCtD
Carvedilol—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00445	CcSEcCtD
Carvedilol—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00197	0.00444	CcSEcCtD
Carvedilol—CYP1A1—kidney—nephrolithiasis	0.00197	0.00731	CbGeAlD
Carvedilol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00195	0.0044	CcSEcCtD
Carvedilol—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00434	CcSEcCtD
Carvedilol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00425	CcSEcCtD
Carvedilol—CYP2E1—renal system—nephrolithiasis	0.00185	0.00689	CbGeAlD
Carvedilol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00414	CcSEcCtD
Carvedilol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00183	0.00411	CcSEcCtD
Carvedilol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00409	CcSEcCtD
Carvedilol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00406	CcSEcCtD
Carvedilol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00404	CcSEcCtD
Carvedilol—CYP2E1—kidney—nephrolithiasis	0.00179	0.00666	CbGeAlD
Carvedilol—PTGS1—renal system—nephrolithiasis	0.00179	0.00664	CbGeAlD
Carvedilol—ADRA2A—cortex of kidney—nephrolithiasis	0.00178	0.00663	CbGeAlD
Carvedilol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00178	0.004	CcSEcCtD
Carvedilol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00176	0.00395	CcSEcCtD
Carvedilol—CYP2E1—cortex of kidney—nephrolithiasis	0.00175	0.00649	CbGeAlD
Carvedilol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00174	0.00392	CcSEcCtD
Carvedilol—Pain—Hydrochlorothiazide—nephrolithiasis	0.00173	0.00389	CcSEcCtD
Carvedilol—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00173	0.00389	CcSEcCtD
Carvedilol—PTGS1—kidney—nephrolithiasis	0.00173	0.00642	CbGeAlD
Carvedilol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00375	CcSEcCtD
Carvedilol—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00165	0.00372	CcSEcCtD
Carvedilol—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0016	0.00361	CcSEcCtD
Carvedilol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0016	0.0036	CcSEcCtD
Carvedilol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0016	0.0036	CcSEcCtD
Carvedilol—CYP3A4—renal system—nephrolithiasis	0.00149	0.00555	CbGeAlD
Carvedilol—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00335	CcSEcCtD
Carvedilol—CYP2D6—renal system—nephrolithiasis	0.00147	0.00546	CbGeAlD
Carvedilol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00145	0.00326	CcSEcCtD
Carvedilol—CYP3A4—kidney—nephrolithiasis	0.00144	0.00536	CbGeAlD
Carvedilol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00322	CcSEcCtD
Carvedilol—CYP2D6—kidney—nephrolithiasis	0.00142	0.00528	CbGeAlD
Carvedilol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00138	0.00311	CcSEcCtD
Carvedilol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00134	0.00301	CcSEcCtD
Carvedilol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00128	0.00289	CcSEcCtD
Carvedilol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00287	CcSEcCtD
Carvedilol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00287	CcSEcCtD
Carvedilol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00285	CcSEcCtD
Carvedilol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0012	0.0027	CcSEcCtD
Carvedilol—ABCB1—nephron tubule—nephrolithiasis	0.00116	0.00432	CbGeAlD
Carvedilol—ABCB1—renal system—nephrolithiasis	0.00106	0.00393	CbGeAlD
Carvedilol—ABCB1—kidney—nephrolithiasis	0.00102	0.0038	CbGeAlD
Carvedilol—ABCB1—cortex of kidney—nephrolithiasis	0.000994	0.0037	CbGeAlD
Carvedilol—XDH—Metabolism—AGXT—nephrolithiasis	0.000503	0.00175	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000501	0.00175	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000495	0.00172	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.000489	0.0017	CbGpPWpGaD
Carvedilol—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000478	0.00166	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—ADCY10—nephrolithiasis	0.000474	0.00165	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—ADCY10—nephrolithiasis	0.000473	0.00165	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—SLC7A9—nephrolithiasis	0.000472	0.00164	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—DGKH—nephrolithiasis	0.000472	0.00164	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000468	0.00163	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000461	0.0016	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—DGKH—nephrolithiasis	0.000461	0.0016	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000455	0.00158	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000446	0.00155	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—RGS14—nephrolithiasis	0.000444	0.00155	CbGpPWpGaD
Carvedilol—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000444	0.00155	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.000442	0.00154	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—SLC7A9—nephrolithiasis	0.000441	0.00154	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—DGKH—nephrolithiasis	0.000441	0.00154	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000436	0.00152	CbGpPWpGaD
Carvedilol—XDH—Metabolism—APRT—nephrolithiasis	0.000428	0.00149	CbGpPWpGaD
Carvedilol—XDH—Metabolism—SLC26A1—nephrolithiasis	0.000428	0.00149	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.000423	0.00147	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000419	0.00146	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000419	0.00146	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—PTH—nephrolithiasis	0.000416	0.00145	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.000413	0.00144	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000409	0.00143	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.000406	0.00141	CbGpPWpGaD
Carvedilol—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000406	0.00141	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.000405	0.00141	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—RGS14—nephrolithiasis	0.000403	0.0014	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—RGS14—nephrolithiasis	0.000402	0.0014	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—RGS14—nephrolithiasis	0.000401	0.0014	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.000396	0.00138	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—PTH—nephrolithiasis	0.000387	0.00135	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000385	0.00134	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000382	0.00133	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00038	0.00132	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000377	0.00131	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—RGS14—nephrolithiasis	0.000375	0.0013	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000373	0.0013	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.000369	0.00128	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000367	0.00128	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000361	0.00126	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.000358	0.00125	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.000358	0.00125	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.000357	0.00124	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.000352	0.00123	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000351	0.00122	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—PTH—nephrolithiasis	0.000349	0.00122	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.000345	0.0012	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000341	0.00119	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000341	0.00119	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—PTH—nephrolithiasis	0.000335	0.00117	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000335	0.00117	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—CHRM3—nephrolithiasis	0.000333	0.00116	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.00033	0.00115	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000328	0.00114	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—PTH—nephrolithiasis	0.000326	0.00114	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.000321	0.00112	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000312	0.00109	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000309	0.00107	CbGpPWpGaD
Carvedilol—XDH—Metabolism—AQP1—nephrolithiasis	0.000305	0.00106	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—PTH—nephrolithiasis	0.000305	0.00106	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000304	0.00106	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000301	0.00105	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—DGKH—nephrolithiasis	0.0003	0.00104	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000298	0.00104	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000295	0.00103	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00029	0.00101	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.000285	0.000993	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.000281	0.000979	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000279	0.00097	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000279	0.00097	CbGpPWpGaD
Carvedilol—XDH—Metabolism—CHRM3—nephrolithiasis	0.000276	0.000959	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.000275	0.000958	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000274	0.000955	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.000273	0.000952	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000272	0.000948	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—DGKH—nephrolithiasis	0.000272	0.000948	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—DGKH—nephrolithiasis	0.000272	0.000946	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000272	0.000946	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.000271	0.000943	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.000267	0.000931	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000265	0.000922	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GRHPR—nephrolithiasis	0.000265	0.000922	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.000264	0.00092	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	0.000262	0.000914	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ADCY10—nephrolithiasis	0.00026	0.000906	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000259	0.000901	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000259	0.000901	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000256	0.000892	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000253	0.000881	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000249	0.000867	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000244	0.000848	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000241	0.000838	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000241	0.000838	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	0.000239	0.000833	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000239	0.000832	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.000237	0.000825	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AGXT—nephrolithiasis	0.000236	0.000821	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AGXT—nephrolithiasis	0.000235	0.00082	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.000234	0.000814	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000228	0.000792	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000226	0.000788	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	0.000221	0.000771	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000221	0.00077	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000219	0.000761	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.000218	0.000758	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000218	0.000758	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000217	0.000755	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000216	0.000751	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.000215	0.000749	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000214	0.000747	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000214	0.000747	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000213	0.000741	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000211	0.000736	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—SPP1—nephrolithiasis	0.000209	0.000727	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000206	0.000716	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000201	0.000702	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—APRT—nephrolithiasis	0.000201	0.000698	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	0.000201	0.000698	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.0002	0.000697	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—APRT—nephrolithiasis	0.0002	0.000697	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	0.000199	0.000693	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	0.000198	0.000691	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000198	0.00069	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000198	0.000688	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.000197	0.000687	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000197	0.000687	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CHRM3—nephrolithiasis	0.000197	0.000685	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CHRM3—nephrolithiasis	0.000196	0.000684	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000196	0.000682	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.000195	0.000678	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.000193	0.000674	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000193	0.000673	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.000192	0.000667	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000186	0.000648	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000184	0.000642	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.000183	0.000637	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000181	0.000631	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	0.000181	0.00063	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00018	0.000627	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—PTH—nephrolithiasis	0.00018	0.000627	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.00018	0.000626	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—PTH—nephrolithiasis	0.00018	0.000625	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.000179	0.000624	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000177	0.000617	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	0.000177	0.000617	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.000177	0.000616	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000176	0.000613	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AGXT—nephrolithiasis	0.000176	0.000613	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000171	0.000597	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	0.000167	0.000583	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000166	0.000578	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.000165	0.000573	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000164	0.00057	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000163	0.000567	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000163	0.000567	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	0.000162	0.000562	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000162	0.000562	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000161	0.000561	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00016	0.000557	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.00016	0.000557	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00016	0.000557	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.000158	0.00055	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000158	0.00055	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.00015	0.000521	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	0.00015	0.000521	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APRT—nephrolithiasis	0.00015	0.000521	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000149	0.000521	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	0.000149	0.000521	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000149	0.000518	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000149	0.000517	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000147	0.000512	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000147	0.000512	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000146	0.000509	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AQP1—nephrolithiasis	0.000143	0.000498	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AQP1—nephrolithiasis	0.000143	0.000497	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000141	0.000491	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000141	0.000491	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.00014	0.000488	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000139	0.000484	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000136	0.000473	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000133	0.000461	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000131	0.000455	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000131	0.000455	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—CHRM3—nephrolithiasis	0.000129	0.00045	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—CHRM3—nephrolithiasis	0.000129	0.000449	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000128	0.000446	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000125	0.000435	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000124	0.000431	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000121	0.000423	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000121	0.000423	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000119	0.000413	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	0.000117	0.000408	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	0.000117	0.000407	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000116	0.000404	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000116	0.000403	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.000114	0.000398	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000113	0.000392	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APRT—nephrolithiasis	0.000113	0.000392	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000108	0.000376	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PTH—nephrolithiasis	0.000107	0.000372	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AQP1—nephrolithiasis	0.000107	0.000371	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000106	0.00037	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000106	0.00037	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000106	0.00037	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.000106	0.000368	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000106	0.000368	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000105	0.000366	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000105	0.000366	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000105	0.000366	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.000104	0.000364	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AQP1—nephrolithiasis	0.000101	0.00035	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	9.89e-05	0.000344	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	9.73e-05	0.000339	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CHRM3—nephrolithiasis	9.64e-05	0.000336	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	9.45e-05	0.000329	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GRHPR—nephrolithiasis	9.16e-05	0.000319	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CHRM3—nephrolithiasis	9.09e-05	0.000317	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SPP1—nephrolithiasis	9.03e-05	0.000315	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SPP1—nephrolithiasis	9.01e-05	0.000314	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	8.99e-05	0.000313	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APRT—nephrolithiasis	8.99e-05	0.000313	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	8.78e-05	0.000306	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	8.64e-05	0.000301	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AGXT—nephrolithiasis	8.16e-05	0.000284	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	8.03e-05	0.00028	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AQP1—nephrolithiasis	8.03e-05	0.00028	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AQP1—nephrolithiasis	7.57e-05	0.000263	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AQP1—nephrolithiasis	7.5e-05	0.000261	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CHRM3—nephrolithiasis	7.26e-05	0.000253	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APRT—nephrolithiasis	6.94e-05	0.000242	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	6.94e-05	0.000242	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CHRM3—nephrolithiasis	6.84e-05	0.000238	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CHRM3—nephrolithiasis	6.78e-05	0.000236	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AQP1—nephrolithiasis	6.41e-05	0.000223	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	5.88e-05	0.000205	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CHRM3—nephrolithiasis	5.8e-05	0.000202	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	5.36e-05	0.000187	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	5.31e-05	0.000185	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	5.25e-05	0.000183	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	4.96e-05	0.000173	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AQP1—nephrolithiasis	4.95e-05	0.000172	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	4.88e-05	0.00017	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CHRM3—nephrolithiasis	4.47e-05	0.000156	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	4.34e-05	0.000151	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	4.03e-05	0.00014	CbGpPWpGaD
